ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag tuberculosis cancer fda genetics genomics

Bugs as Drugs to Boost Cancer Therapy
Danielle Gerhard, PhD | Jan 18, 2024 | 7 min read
Bioengineered bacteria sneak past solid tumor defenses to guide CAR T cells’ attacks.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Diagnosing Cancer: A Genomics and Proteomics Approach
Tom Hollon | Sep 21, 2003 | 7 min read
In 1996, Jeff Trent and colleagues published the first paper describing DNA microarrays as tools for pinpointing gene variants underlying various tumor properties.1 Now, as president and scientific director of Translational Genomics Research Institute (TGEN), in Phoenix, Trent is using microarrays to look for gene expression patterns that can be applied to developing diagnostics. The role of microarrays, Trent says, "will be on the discovery side. Testing all 30,000 genes against a diagnosti
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Those We Lost in 2018
Ashley Yeager | Dec 26, 2018 | 10+ min read
The scientific community said goodbye to a number of leading researchers this year.
Deploying the Body’s Army
Jamie Green and Charlotte Ariyan | Apr 1, 2014 | 10+ min read
Using patients’ own immune systems to fight cancer
COVID-19, SARS-CoV-2, coronavirus, pandemic, pseudovirus, chimeric virus, disease & medicine, techniques, HIV, VSV, vaccine, variants, mutations
What Pseudoviruses Bring to the Study of SARS-CoV-2
Amanda Heidt | Feb 16, 2021 | 7 min read
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
Therapeutic MAbs: Saving Lives and Making Billions
Kelli Miller Stacy(kstacy@the-scientist.com) | Feb 13, 2005 | 8 min read
In 1895 two French physicians attempted a radical departure from the standard cancer treatment regimen.
The Rise of Free, Global Gene Expression Data Sets
Jim Kling | Apr 1, 2002 | 5 min read
See related Techlink, "The Data Analysis Grand Prix". For this article, Jim Kling interviewed Patrick O. Brown, Howard Hughes Medical Institute investigator and professor in the department of biochemistry, Stanford University Medical School in Stanford, Calif., and John N. Weinstein, senior investigator at the National Cancer Institute and head of the genomics and bioinformatics group, in Bethesda, Md. Data from the Web of Science show that Hot Papers are cited 50 to 100 times more often than t
2019 Top 10 Innovations
The Scientist | Dec 1, 2019 | 10+ min read
From a mass photometer to improved breath biopsy probes, these new products are poised for scientific success.

Run a Search

ADVERTISEMENT